Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Other Working Capital Changes (2016 - 2026)

Cytosorbents filings provide 15 years of Other Working Capital Changes readings, the most recent being -$802000.0 for Q4 2025.

  • On a quarterly basis, Other Working Capital Changes fell 80300.0% to -$802000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$150931.0, a 107.18% decrease, with the full-year FY2025 number at $373775.0, down 53.11% from a year prior.
  • Other Working Capital Changes hit -$802000.0 in Q4 2025 for Cytosorbents, down from $908000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $1.5 million in Q4 2022 to a low of -$802000.0 in Q4 2025.
  • Median Other Working Capital Changes over the past 5 years was $127032.5 (2022), compared with a mean of $237098.4.
  • Biggest five-year swings in Other Working Capital Changes: surged 166571.72% in 2022 and later plummeted 80300.0% in 2025.
  • Cytosorbents' Other Working Capital Changes stood at -$916.0 in 2021, then surged by 166571.72% to $1.5 million in 2022, then dropped by 10.12% to $1.4 million in 2023, then crashed by 99.93% to $1000.0 in 2024, then plummeted by 80300.0% to -$802000.0 in 2025.
  • The last three reported values for Other Working Capital Changes were -$802000.0 (Q4 2025), $908000.0 (Q3 2025), and $187177.0 (Q2 2025) per Business Quant data.